HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.9% | 1,000 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -55.6% | 1,000 | -66.7% | 0.00% | – |
| Q2 2022 | $9,000 | -47.1% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $17,000 | -37.0% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | -15.6% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $32,000 | -31.9% | 3,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $47,000 | -2.1% | 3,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $48,000 | +14.3% | 3,000 | +50.0% | 0.00% | 0.0% |
| Q4 2020 | $42,000 | +366.7% | 2,000 | +233.3% | 0.00% | +100.0% |
| Q3 2020 | $9,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |